QIAGEN N.V. (QGEN) at a glance

QIAGEN N.V. (QGEN) is a mid-cap Healthcare company. It trades at $42.5, with a P/E of 18.9, a 19.2% profit margin and revenue growth of 1.8%. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Value (75/100) and its weakest is Growth (28/100). It is a relatively defensive holding with below-market volatility.

Price

$42.50

Market cap

$7.64B

P/E ratio

18.9

Dividend yield

None

Beta

0.66

52-week range

$32.53 to $57.82